Clinical Trials Browser

Interventional × Pharmacogenomic Testing × Other solid neoplasm × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT02399371 2025-06-11

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT01713972 2019-03-01

Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01705106 2018-05-30

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Phase 1 Terminated

21 enrolled 5 charts

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00731276 2017-03-31

Irinotecan in Treating Asian Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01096355 2014-04-02

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific